Navigation Links
Aesthera Announces Installation of 1000th Photopneumatic System in US
Date:6/4/2009

Over 1800 Systems Installed Worldwide in Under 4 years

PLEASANTON, Calif., June 4 /PRNewswire/ -- Aesthera today announced the installation of its 1000th Photopneumatic system in the United States. The installation of the 1000th system in the United States brings Aesthera's total installed base to approximately 1800 systems worldwide. The company has direct operations in the United States and Japan and a network of distributors in over 20 countries in Asia, Europe and the Middle East.

The 1000th Photopneumatic platform - the Isolaz Pro - was installed at the offices of Amy A. Vaughan, MD, of Amy A. Vaughan Dermatology, PLLC, a dermatologist in private practice in Barboursville, West Virginia. "Antibiotic resistance to acne is a growing concern for dermatologists and a rapidly growing number of physicians are moving away from using antibiotics as a primary weapon in the battle against acne. Even those physicians that do use antibiotics, often combine them with other treatment modalities that lessen drug resistance," says Dr. Vaughan. "Against this landscape, offering Isolaz treatments, especially to treat the more severe kinds of acne, was an obvious choice for our practice," she adds. Aesthera's Isolaz platform is the only FDA cleared device for the treatment of comedonal and pustular acne, in addition to a broad range of other indications, the company adds.

"The installation of our 1000th US system in less than 4 years post commercialization is a landmark achievement," says Alon Maor, Aesthera's President & CEO. During this period, the company commercialized its proprietary photopneumatic therapy, established the Isolaz as the premier treatment solution for acne and brought to market Profusion(TM) - a breakthrough skin therapy that combines Photopneumatic light treatments with the delivery of Aesthera's proprietary skincare to symbiotically enhance skin treatment outcomes for acne, body tightening, skin rejuvenation and skin lightening. "We are proud to be celebrating our 5th year in business and will continue to develop treatment solutions that strengthen our leadership position in the dermatology market," he adds.

About Photopneumatic(TM) Technology

Photopneumatic Therapy, that powers the Isolaz(TM) and Isolaz Pro(TM) system, is a proprietary combination of pneumatic energy and broad band light. Photopneumatic devices are the only laser or light based devices cleared for the treatment of inflammatory acne, comedonal acne and pustular acne. They are also cleared for the treatment of mild to moderate inflammatory acne. Additionally, Photopneumatic treatments have an immediate visible impact on acne 24 - 48 hour post first treatment and are painless. Facial treatments take approximately 10 minutes, require no anesthetics or numbing creams and provide additional cosmetic benefits such as smoother appearing skin. Additionally, Photopneumatic Therapy is also cleared for the treatment of benign vascular and pigmented lesions and hair removal.

About Aesthera Corporation

Aesthera (www.AESTHERA.com) develops, manufactures and markets light-based aesthetic treatment systems - the Isolaz(TM) and Isolaz Pro(TM) platforms - based on proprietary Photopneumatic(TM) technology.

About Amy A. Vaughan, MD

Dr. Amy A. Vaughan, MD is a board certified dermatologist. Her private practice, Amy A. Vaughan Dermatology, PLLC is located in Barboursville, WV. To contact Dr. Vaughan or schedule an appointment, please call 304.733.3333

    Contact:
    Sarvar Kothavala
    Aesthera Corp.
    415.760.0902
    SKothavala@Aesthera.com


'/>"/>
SOURCE Aesthera
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Aesthera Announces Breakthrough Innovations at 2009 American Academy of Dermatology (AAD) Meeting
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... ... to fertility once they have been diagnosed with endometriosis. These women need a ... they also require a comprehensive approach that can help for preservation of fertility ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. ... articles published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
Breaking Medicine Technology: